$VICR

Schmidt James F sold $111K of VICR

Schmidt James F (CFO, Treasurer, Secretary) sold 331 shares of VICOR CORP (VICR) at $334.90 ($0.11M total) on 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schmidt James F
Published Jun 25, 2026, 3:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 3:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
high confidence
Mentioned
$VICR
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details (331 shares at $334.90) and the post-trade holding of 0 shares, executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider’s position reduction, but the 10b5-1 framing and lack of operational updates make it unlikely to drive a fundamental repricing.

03

What to watch

10b5-1 sales are often scheduled for liquidity/tax needs; without additional context (e.g., other concurrent buys/sales), the signal is weak.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-25 for a sale executed 2026-06-24

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

VICOR CFO James F Schmidt sold 331 shares at $334.90 via a Rule 10b5-1 plan, leaving 0 shares after the trade.

Expected impact

Likely minimal immediate impact; any effect would be second-order sentiment rather than a new fundamental catalyst.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan and a small absolute share count; no new company-specific operational or financial information is disclosed.

Market effects

No sector read-through; this is a single-company insider sale with no disclosed business change.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, a complete position exit (0 shares remaining) can still be interpreted by some traders as a mild negative sentiment signal.

Key entities

  • VICOR CORP

    Company whose insider transaction is disclosed on Form 4.

  • Schmidt James F

    CFO/Treasurer/Secretary who executed the sale under a Rule 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: